These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 24746164)

  • 1. Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science.
    Hochberg FH; Atai NA; Gonda D; Hughes MS; Mawejje B; Balaj L; Carter RS
    Expert Rev Mol Diagn; 2014 May; 14(4):439-52. PubMed ID: 24746164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Vesicles as a Platform for Glioma Therapeutic Development.
    Santiago-Dieppa DR; Gonda DD; Cheung VJ; Steinberg JA; Carter BS; Chen CC
    Prog Neurol Surg; 2018; 32():172-179. PubMed ID: 29990983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ExRNA in Biofluids as Biomarkers for Brain Tumors.
    Rennert RC; Hochberg FH; Carter BS
    Cell Mol Neurobiol; 2016 Apr; 36(3):353-60. PubMed ID: 26993514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biomarkers of glioma: recent advance and potential applications].
    Yu SZ; Wang Q
    Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):145-7. PubMed ID: 19575846
    [No Abstract]   [Full Text] [Related]  

  • 6. Biomarkers usher in era of personalized care for malignant glioma patients.
    Chakravarti A; Palanichamy K; Bell EH
    CNS Oncol; 2012 Sep; 1(1):3-6. PubMed ID: 25054291
    [No Abstract]   [Full Text] [Related]  

  • 7. The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring.
    Hallal S; Ebrahimkhani S; Shivalingam B; Graeber MB; Kaufman KL; Buckland ME
    Brain Tumor Pathol; 2019 Apr; 36(2):29-39. PubMed ID: 30859343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuro-oncology: Implications of the molecular era.
    Ruff MW; Uhm JH; Benarroch EE
    Neurology; 2019 Mar; 92(12):568-574. PubMed ID: 30760635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of extracellular vesicles as non-invasive biomarkers in glioma diagnosis, prognosis, and treatment response monitoring.
    Sourani A; Saghaei S; Sabouri M; Soleimani M; Dehghani L
    Mol Biol Rep; 2021 Oct; 48(10):6971-6985. PubMed ID: 34460059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FASN Is a Biomarker Enriched in Malignant Glioma-Derived Extracellular Vesicles.
    Ricklefs FL; Maire CL; Matschke J; Dührsen L; Sauvigny T; Holz M; Kolbe K; Peine S; Herold-Mende C; Carter B; Chiocca EA; Lawler SE; Westphal M; Lamszus K
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32178271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extracellular vesicles for diagnosis and therapy of gliomas: problems and opportunities].
    Filin AA; Chernysheva AA; Pavlova GV; Loshhenov VB; Gurina OI
    Biomed Khim; 2022 Dec; 68(6):419-426. PubMed ID: 36573408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma-derived extracellular vesicles promote tumor progression by conveying WT1.
    Tsutsui T; Kawahara H; Kimura R; Dong Y; Jiapaer S; Sabit H; Zhang J; Yoshida T; Nakada M; Hanayama R
    Carcinogenesis; 2020 Sep; 41(9):1238-1245. PubMed ID: 32463428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating biomarkers for high-grade glioma.
    Loo HK; Mathen P; Lee J; Camphausen K
    Biomark Med; 2019 Feb; 13(3):161-165. PubMed ID: 30806515
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical practice guidelines for the management of adult diffuse gliomas.
    Jiang T; Nam DH; Ram Z; Poon WS; Wang J; Boldbaatar D; Mao Y; Ma W; Mao Q; You Y; Jiang C; Yang X; Kang C; Qiu X; Li W; Li S; Chen L; Li X; Liu Z; Wang W; Bai H; Yao Y; Li S; Wu A; Sai K; Li G; Yao K; Wei X; Liu X; Zhang Z; Dai Y; Lv S; Wang L; Lin Z; Dong J; Xu G; Ma X; Zhang W; Zhang C; Chen B; You G; Wang Y; Wang Y; Bao Z; Yang P; Fan X; Liu X; Zhao Z; Wang Z; Li Y; Wang Z; Li G; Fang S; Li L; Liu Y; Liu S; Shan X; Liu Y; Chai R; Hu H; Chen J; Yan W; Cai J; Wang H; Chen L; Yang Y; Wang Y; Han L; Wang Q; ; ; ; ;
    Cancer Lett; 2021 Feb; 499():60-72. PubMed ID: 33166616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma.
    Weller M; van den Bent M; Hopkins K; Tonn JC; Stupp R; Falini A; Cohen-Jonathan-Moyal E; Frappaz D; Henriksson R; Balana C; Chinot O; Ram Z; Reifenberger G; Soffietti R; Wick W;
    Lancet Oncol; 2014 Aug; 15(9):e395-403. PubMed ID: 25079102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance.
    Hallal S; Russell BP; Wei H; Lee MYT; Toon CW; Sy J; Shivalingam B; Buckland ME; Kaufman KL
    Proteomics; 2019 Jan; 19(1-2):e1800157. PubMed ID: 30451371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNAs: potential molecular biomarkers for gliomas diagnosis and prognosis.
    Wang L; Yu Z; Sun S; Peng J; Xiao R; Chen S; Zuo X; Cheng Q; Xia Y
    Rev Neurosci; 2017 May; 28(4):375-380. PubMed ID: 28107175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Satisfying your neuro-oncologist: a fast approach to routine molecular glioma diagnostics.
    Hench J; Bihl M; Bratic Hench I; Hoffmann P; Tolnay M; Bösch Al Jadooa N; Mariani L; Capper D; Frank S
    Neuro Oncol; 2018 Nov; 20(12):1682-1683. PubMed ID: 30169880
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress in the study of markers related to glioma prognosis.
    Luo Y; Hou WT; Zeng L; Li ZP; Ge W; Yi C; Kang JP; Li WM; Wang F; Wu DB; Wang RY; Qu BL; Li XF; Wang JJ
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7690-7697. PubMed ID: 32744695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
    Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
    Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.